How should a floor‑of‑mouth mass be evaluated and managed?

Floor of Mouth Mass: Evaluation and Management

A floor-of-mouth mass in an adult requires immediate risk stratification for malignancy, followed by contrast-enhanced CT or MRI imaging and fine-needle aspiration (FNA) rather than open biopsy, with surgical excision reserved for definitive treatment after complete diagnostic workup including examination under anesthesia if the primary site remains unidentified.

Initial Risk Stratification for Malignancy

Begin by determining if the patient is at increased risk for malignancy using these specific criteria 1:

History-Based Red Flags (any one indicates high risk):

• Mass present ≥2 weeks without significant fluctuation or uncertain duration
• No recent infectious etiology
• Age >40 years
• Tobacco and/or alcohol use
• Prior head and neck cancer or radiation treatment
• Unexplained weight loss

Physical Examination Red Flags (any one indicates high risk):

• Fixation to adjacent tissues (reduced mobility)
• Firm consistency
• Size >1.5 cm
• Ulceration of overlying skin
• Nontender mass

Additional Concerning Symptoms:

• Dysphagia or odynophagia
• Voice change
• Ipsilateral otalgia with normal ear exam
• Oral cavity or oropharyngeal ulcer
• Decreased tongue mobility
• Tonsil asymmetry

Critical Point: Do NOT prescribe antibiotics unless there are clear signs of bacterial infection (warmth, erythema, localized swelling, tenderness, fever >101°F) 1. Inappropriate antibiotic use delays cancer diagnosis and contributes to bacterial resistance.

Diagnostic Workup Algorithm

For Patients at Increased Risk for Malignancy:

Step 1: Targeted Physical Examination 1

• Perform or refer for visualization of the larynx, base of tongue, and pharynx (typically via flexible laryngoscopy)
• Examine for skin lesions on face, neck, and scalp
• Assess for cervical lymphadenopathy bilaterally

Step 2: Imaging (STRONG RECOMMENDATION) 1

• Order CT neck with contrast (or MRI with contrast if CT contraindicated)
• This is a strong recommendation from the 2017 AAO-HNS guidelines
• Imaging alone should NOT determine management—preoperative imaging is inaccurate 34% of the time in floor-of-mouth masses 2
• MRI is particularly valuable for defining the relationship to the mylohyoid muscle, which determines surgical approach 3

Step 3: Fine-Needle Aspiration (STRONG RECOMMENDATION) 1, 4, 1

• Perform FNA instead of open biopsy when diagnosis remains uncertain after imaging
• FNA has low complication risk (bleeding, bruising, infection, inadequate tissue)
• Results should be available within 1 week 4
• Core needle biopsy is an alternative if FNA is non-diagnostic

Step 4: If Diagnosis Still Uncertain 1

• Obtain ancillary tests based on clinical suspicion (e.g., HPV testing, EBV serology)
• Do NOT assume cystic masses are benign—continue evaluation until diagnosis is confirmed 1, 4, 1

Step 5: Examination Under Anesthesia 1, 4, 1

• Recommend before any open biopsy if no diagnosis or primary site identified
• Allows complete evaluation of nasopharynx, oropharynx, larynx, hypopharynx, and upper esophagus
• Permits directed biopsies of suspicious areas

Management Based on Diagnosis

Malignant Lesions (Floor of Mouth Squamous Cell Carcinoma):

Surgery remains the dominant treatment modality for floor-of-mouth cancers 5:

• Surgical local control: 85%
• Radiotherapy-only local control: 23% (77% failure rate)
• Wide surgical excision with appropriate reconstruction
• Neck dissection for regional control (at least levels I-III for oral cavity) 6
• Risk-adapted postoperative radiotherapy or chemoradiotherapy based on pathology 7, 6

Benign Cystic Lesions:

Surgical excision is the definitive treatment regardless of suspected pathology 2, 8:

Recurrence rates by treatment modality 2:

• Surgical excision: 8.8%
• Marsupialization: 80%
• Sclerotherapy: 100%
• Chemical injection: 50%
• Radiation: 100%

Surgical approach depends on anatomic location 8:

• Sublingual cysts (above mylohyoid): Intraoral approach via midline incision along lingual frenulum
• Genioglossal cysts: Median glossotomy or extended glossotomy for large lesions
• Geniohyoid cysts (below mylohyoid): Transcutaneous approach

For Patients NOT at Increased Risk:

• Advise patient of criteria requiring re-evaluation 1
• Document follow-up plan to assess resolution
• Re-evaluate if mass persists >2-3 weeks or develops concerning features

Critical Pitfalls to Avoid

1. Never perform open biopsy before examination under anesthesia in high-risk patients—this can seed tumor and complicate subsequent treatment 1, 4, 1

2. Do not rely on imaging alone to determine benign versus malignant pathology—imaging is inaccurate in 34% of floor-of-mouth masses 2

3. Never assume cystic masses are benign—cystic metastatic lymph nodes and cystic squamous cell carcinomas occur frequently 1

4. Avoid needle aspiration for diagnosis—it offers limited pathologic information and should only be used for acute symptomatic management 2

5. Do not delay referral with empiric antibiotics unless clear infectious signs are present 1

Patient Education

Explain to high-risk patients 1:

• The significance of being at increased risk for malignancy
• The diagnostic tests recommended and their urgency
• Expected timeline for results (within 1 week for FNA) 4
• The need for complete evaluation until definitive diagnosis is obtained